Session Track · PDDS 2027 · Track 16

Drug Discovery and Development at PDDS 2027

Part of the PDDS 2027 scientific program · Olympia Hotel, Events & Spa, Valencia, Spain · September 13–15, 2027

About the Drug Discovery and Development Session

Drug discovery and development involve a complex and rigorous process that bridges scientific innovation and clinical application. The journey begins with the identification of novel drug targets, followed by the screening of potential compounds that could interact with these targets. Advances in high-throughput screening, computational modeling, and synthetic biology have significantly accelerated this phase. Once promising compounds are identified, they undergo preclinical testing, where efficacy, toxicity, and pharmacokinetics are carefully evaluated. The subsequent clinical trials phase further refines drug candidates, ensuring safety and effectiveness in human populations. Innovations in drug delivery systems are playing a crucial role in enhancing the bioavailability and precision of treatments. As the pharmaceutical landscape evolves, drug discovery and development continue to benefit from new technologies and interdisciplinary collaboration, paving the way for breakthrough therapies.

Featured Speakers — Drug Discovery and Development 2027

Speaker lineup for this track will be announced soon.

Browse all speakers →

Recent Research Presented at Drug Discovery and Development Sessions

Selected abstracts from this track will be published here.

Related Scientific Sessions at PDDS 2027

Why Attend the Drug Discovery and Development Conference 2027

Present Your Research

Oral and poster slots for original Drug Discovery and Development work, reviewed by the scientific committee.

Network Globally

Meet researchers, clinicians, and industry leaders from around the world across three days.

Learn from Keynotes

Plenary lectures from leading voices shaping Drug Discovery and Development research and practice.

Hybrid Flexibility

Attend in person in Valencia or join virtually — same program, same certificate.

Join PDDS 2027 for the Drug Discovery and Development track

Oral and poster slots for your work — in person in Valencia or online. Not presenting? Attend as a delegate to learn from the field.

Drug Discovery and Development Conference 2027 — FAQs

What is the Drug Discovery and Development track at PDDS 2027?

The Drug Discovery and Development track is a dedicated stream within PDDS 2027 covering the latest research, clinical innovation, and best practice in Drug Discovery and Development. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Drug Discovery and Development sessions?

Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Drug Discovery and Development are all welcome — whether presenting or attending.

Can I present my research in the Drug Discovery and Development track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee.

Is virtual attendance available for Drug Discovery and Development sessions?

Yes. PDDS 2027 is a hybrid conference — attend the Drug Discovery and Development track in person in Valencia or join live online, with on-demand access afterward.

Join the PDDS 2027 delegation

Valencia · September 13–15, 2027 · Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.